1. Home
  2. ARCT vs MYD Comparison

ARCT vs MYD Comparison

Compare ARCT & MYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • MYD
  • Stock Information
  • Founded
  • ARCT 2013
  • MYD 1991
  • Country
  • ARCT United States
  • MYD United States
  • Employees
  • ARCT N/A
  • MYD N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • MYD Investment Bankers/Brokers/Service
  • Sector
  • ARCT Health Care
  • MYD Finance
  • Exchange
  • ARCT Nasdaq
  • MYD Nasdaq
  • Market Cap
  • ARCT 487.0M
  • MYD 479.5M
  • IPO Year
  • ARCT N/A
  • MYD N/A
  • Fundamental
  • Price
  • ARCT $16.79
  • MYD $10.64
  • Analyst Decision
  • ARCT Strong Buy
  • MYD
  • Analyst Count
  • ARCT 7
  • MYD 0
  • Target Price
  • ARCT $65.00
  • MYD N/A
  • AVG Volume (30 Days)
  • ARCT 400.9K
  • MYD 253.1K
  • Earning Date
  • ARCT 03-06-2025
  • MYD 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • MYD 4.55%
  • EPS Growth
  • ARCT N/A
  • MYD N/A
  • EPS
  • ARCT N/A
  • MYD N/A
  • Revenue
  • ARCT $160,399,000.00
  • MYD N/A
  • Revenue This Year
  • ARCT $7.33
  • MYD N/A
  • Revenue Next Year
  • ARCT $4.71
  • MYD N/A
  • P/E Ratio
  • ARCT N/A
  • MYD N/A
  • Revenue Growth
  • ARCT N/A
  • MYD N/A
  • 52 Week Low
  • ARCT $14.30
  • MYD $8.76
  • 52 Week High
  • ARCT $45.00
  • MYD $11.30
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 46.15
  • MYD 47.17
  • Support Level
  • ARCT $16.07
  • MYD $10.42
  • Resistance Level
  • ARCT $17.95
  • MYD $10.66
  • Average True Range (ATR)
  • ARCT 1.36
  • MYD 0.10
  • MACD
  • ARCT -0.07
  • MYD 0.04
  • Stochastic Oscillator
  • ARCT 14.86
  • MYD 83.33

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About MYD Blackrock MuniYield Fund Inc.

Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: